Drug Profile
RG 7600 companion diagnostic - Genentech
Alternative Names: 89Zr-MMOT0530A; DMOT 4039A companion diagnostic - Genentech; MMOT 0530A Zr 89; Zirconium-89 MMOT 0530ALatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Genentech
- Developer Genentech; University Medical Center Groningen; VU University Medical Center
- Class Drug conjugates; Immunoconjugates; Monoclonal antibodies; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ovarian cancer; Pancreatic cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Ovarian-cancer(Diagnosis) in Netherlands (Parenteral)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Pancreatic-cancer(Diagnosis) in Netherlands (Parenteral)
- 01 May 2014 The University Medical Center Gronigen completes a phase I study for Pancreatic and Ovarian cancer (diagnosis) in the Netherlands (NCT01832116)